Pomalidomide Enhanced Antitumor Effect of Gemcitabine and Nab-Paclitaxel for Pancreatic Cancer Cells

被引：0
|
作者：
Saito, Nobuhiro [1 ]
Shirai, Yoshihiro [1 ]
Sugano, Hiroshi [1 ]
Horiuchi, Takashi [1 ]
Iwase, Ryota [1 ]
Haruki, Koichiro [1 ]
Shiba, Hiroaki [1 ]
Uwagawa, Tadashi [1 ]
Ohashi, Toya [1 ]
Yanaga, Katsuhiko [1 ]
机构：
[1] Jikei Univ, Sch Med, Tokyo, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2016年 / 223卷 / 04期
关键词：
D O I：
10.1016/j.jamcollsurg.2016.08.365
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：E142 / E142
页数：1
相关论文
共 50 条
  • [11] Efficacy and safety of Nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer
    Filipazzi, V.
    Dalu, D.
    Isabella, L.
    Tosca, N.
    Ferrario, S.
    Gambaro, A.
    Somma, L.
    Fasola, C.
    Pellegrini, I.
    Bombonati, G.
    Curcio, R.
    Damiani, E.
    Cattaneo, M. T.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [12] nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: Real life
    Cidon, E. Una
    Alonso, P.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S109 - S109
  • [13] Gemcitabine and nab-paclitaxel combination therapy for the treatment of metastatic pancreatic cancer
    Sasaki, Takashi
    Kanata, Ryo
    Saito, Kei
    Yamada, Ikuhiro
    Matsuyama, Masato
    Ozaka, Masato
    Takano, Kouichi
    Sasahira, Naoki
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [14] Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer
    Comandatore, Annalisa
    Immordino, Benoit
    Balsano, Rita
    Capula, Mjriam
    Garajova, Ingrid
    Ciccolini, Joseph
    Giovannetti, Elisa
    Morelli, Luca
    [J]. DIAGNOSTICS, 2022, 12 (02)
  • [15] Maintenance treatment with gemcitabine after gemcitabine plus Nab-paclitaxel in advanced pancreatic cancer
    Kodama, Tomoko
    Nakazawa, Junichi
    Kawahira, Masahiro
    Ymasuji, Akihiro
    Iwashita, Yuji
    Hori, Takeshi
    Kawahira, Machiko
    Arima, Shiho
    Tubouchi, Hirohito
    Ido, Akio
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S484 - S484
  • [16] nab-Paclitaxel for the treatment of pancreatic cancer
    Kim, George
    [J]. CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 85 - 96
  • [17] Predictors of vulnerability to nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
    Iede, Kiyotsugu
    Yamada, Terumasa
    Tominaga, Shusei
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1453 - S1453
  • [18] Gemcitabine plus Nab-Paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC)
    Olowokure, Olugbenga
    Torregroza-Sanchez, Maria Patricia
    Bedoya-Apraez, Ivan Dario
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (02) : E16 - E18
  • [19] Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer
    Tsujimoto, Akiko
    Sudo, Kentaro
    Nakamura, Kazuyoshi
    Kita, Emiri
    Hara, Ryusuke
    Takayama, Wataru
    Ishii, Hiroshi
    Yamaguchi, Taketo
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [20] Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer
    Muranaka, Tetsuhito
    Kuwatani, Masaki
    Komatsu, Yoshito
    Sawada, Kentaro
    Nakatsumi, Hiroshi
    Kawamoto, Yasuyuki
    Yuki, Satoshi
    Kubota, Yoshimasa
    Kubo, Kimitoshi
    Kawahata, Shuhei
    Kawakubo, Kazumichi
    Kawakami, Hiroshi
    Sakamoto, Naoya
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (03) : 566 - 571
12345